feed,title,long_url,short_url
MarketWatch,ChemoCentryx's stock dives after critique from the FDA about experimental treatment for rare autoimmune disease,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/fRFcO9cBrVA/story.aspx,https://on.mktw.net/3xWcwpA
